Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Salivary secretion (mmu04970)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
Adcy1
KLA  ATP  ATP+KLA
 BC050125 adenylate cyclase 1, mRNA (cDNA clone IMAGE:30015692). [BC050125] KLA 1.05 1.03 .98 1.04 1.05 1.09 1.10
ATP .90 1.02 .99 .97 1.03 .95 1.01
KLA/ATP .99 1.04 .90 .98 .98 1.00 1.03
Adcy1
KLA  ATP  ATP+KLA
 NM_009622 adenylate cyclase 1 (Adcy1), mRNA [NM_009622] KLA 1.07 1.02 1.06 1.07 1.03 1.02 1.01
ATP 1.02 1.04 1.00 .99 .99 .95 .97
KLA/ATP .97 1.05 1.02 1.05 1.01 .98 1.05
Adcy2
KLA  ATP  ATP+KLA
 NM_153534 adenylate cyclase 2 (Adcy2), mRNA [NM_153534] KLA .79 .82 .83 .73 .61 .66 .90
ATP 1.10 1.09 1.02 1.04 .88 .58 .53
KLA/ATP .84 .87 .77 .75 .68 .60 .43
Adcy3
KLA  ATP  ATP+KLA
 NM_138305 adenylate cyclase 3 (Adcy3), mRNA [NM_138305] KLA .84 .84 .83 .78 .66 .55 .49
ATP 1.09 1.05 .89 1.02 .84 .62 1.52
KLA/ATP .93 .87 .75 .85 .66 .83 .77
Adcy4
KLA  ATP  ATP+KLA
 NM_080435 adenylate cyclase 4 (Adcy4), mRNA [NM_080435] KLA 1.05 1.07 .96 1.00 1.04 1.05 1.05
ATP 1.02 1.05 1.02 1.48 1.37 1.08 1.09
KLA/ATP 1.00 1.05 .91 1.19 1.35 1.27 1.08
Adcy5
KLA  ATP  ATP+KLA
 NM_001012765 adenylate cyclase 5 (Adcy5), mRNA [NM_001012765] KLA 1.06 1.00 .97 1.01 1.03 .95 .93
ATP .95 1.08 1.08 1.07 .97 1.03 .97
KLA/ATP .97 .92 1.04 .99 .91 .96 1.04
Adcy6
KLA  ATP  ATP+KLA
 NM_007405 adenylate cyclase 6 (Adcy6), mRNA [NM_007405] KLA 1.10 1.16 1.16 1.09 1.08 1.06 .99
ATP 1.05 .97 1.08 1.12 1.08 1.08 1.04
KLA/ATP 1.14 1.20 1.29 1.30 1.25 1.11 1.07
Adcy7
KLA  ATP  ATP+KLA
 NM_001037724 adenylate cyclase 7 (Adcy7), transcript variant 3, mRNA [NM_001037724] KLA .43 .39 .35 .32 .45 .72 .84
ATP .90 .84 .62 .41 .53 .42 .94
KLA/ATP .39 .34 .23 .17 .41 .34 .67
Adcy7
KLA  ATP  ATP+KLA
 NM_007406 adenylate cyclase 7 (Adcy7), transcript variant 1, mRNA [NM_007406] KLA .51 .52 .48 .41 .59 .81 .99
ATP 1.01 1.02 .62 .52 .53 .38 .98
KLA/ATP .53 .48 .30 .27 .42 .36 .65
Adcy8
KLA  ATP  ATP+KLA
 NM_009623 adenylate cyclase 8 (Adcy8), mRNA [NM_009623] KLA 1.00 1.00 1.07 .97 1.04 .98 1.02
ATP 1.04 1.05 1.14 1.03 .99 1.00 .97
KLA/ATP 1.05 1.04 1.00 1.03 .98 .94 .96
Adcy9
KLA  ATP  ATP+KLA
 NM_009624 adenylate cyclase 9 (Adcy9), mRNA [NM_009624] KLA .18 .15 .13 .15 .17 .19 .33
ATP 1.33 1.16 .97 .98 .62 .56 .86
KLA/ATP .19 .16 .17 .18 .20 .25 .38
Adra1a
KLA  ATP  ATP+KLA
 NM_013461 adrenergic receptor, alpha 1a (Adra1a), mRNA [NM_013461] KLA .78 .74 .75 .85 .96 1.37 2.70
ATP 1.05 1.14 .97 .97 1.69 1.06 2.56
KLA/ATP .76 .75 .83 .84 1.51 1.34 4.08
Adra1b
KLA  ATP  ATP+KLA
 NM_007416 adrenergic receptor, alpha 1b (Adra1b), mRNA [NM_007416] KLA 1.04 .99 .98 1.02 .99 1.00 1.01
ATP 1.00 .99 .98 1.01 1.06 1.01 1.05
KLA/ATP .99 .97 1.03 1.03 1.00 .97 1.08
Adra1d
KLA  ATP  ATP+KLA
 NM_013460 adrenergic receptor, alpha 1d (Adra1d), mRNA [NM_013460] KLA 1.13 1.12 1.21 1.25 1.30 1.34 1.27
ATP 1.02 .99 1.16 1.08 1.13 1.11 1.06
KLA/ATP 1.15 1.10 1.20 1.14 1.24 1.16 1.13
Adrb1
KLA  ATP  ATP+KLA
 NM_007419 adrenergic receptor, beta 1 (Adrb1), mRNA [NM_007419] KLA .88 .86 .88 .86 .87 .87 .87
ATP .97 .97 .95 .89 .89 .90 .87
KLA/ATP .90 .88 .91 .84 .91 .79 .82
Adrb2
KLA  ATP  ATP+KLA
 NM_007420 adrenergic receptor, beta 2 (Adrb2), mRNA [NM_007420] KLA .28 .26 .32 .31 .34 .31 .29
ATP 2.09 2.43 2.74 1.72 .96 .63 .29
KLA/ATP .28 .29 .52 .69 .65 .35 .23
AK078587
KLA  ATP  ATP+KLA
 AK078587 11 days embryo gonad cDNA, RIKEN full-length enriched library, clone:7030411M21 product:unclassifiable, full insert sequence [AK078587] KLA 1.37 1.28 1.13 1.06 1.15 1.31 1.22
ATP 1.04 1.08 1.21 1.22 1.27 1.12 1.14
KLA/ATP 1.48 1.66 1.97 1.26 1.17 1.03 1.28
Aqp5
KLA  ATP  ATP+KLA
 NM_009701 aquaporin 5 (Aqp5), mRNA [NM_009701] KLA .96 1.00 .99 1.01 1.04 .98 1.14
ATP 1.09 .98 1.01 1.04 1.01 1.02 1.04
KLA/ATP .98 .97 .92 .99 1.04 1.03 1.04
Atp1a1
KLA  ATP  ATP+KLA
 NM_144900 ATPase, Na+/K+ transporting, alpha 1 polypeptide (Atp1a1), mRNA [NM_144900] KLA .78 .94 .68 .81 .62 .55 .75
ATP 1.02 1.05 .86 .85 1.77 2.54 1.11
KLA/ATP .83 .99 .80 .75 .91 1.15 .68
Atp1a2
KLA  ATP  ATP+KLA
 NM_178405 ATPase, Na+/K+ transporting, alpha 2 polypeptide (Atp1a2), mRNA [NM_178405] KLA 1.03 .98 1.03 1.05 1.03 .98 1.02
ATP 1.03 .98 1.06 1.05 1.05 .93 1.07
KLA/ATP 1.04 1.05 1.02 1.02 .98 .92 1.02
Atp1a3
KLA  ATP  ATP+KLA
 AK053751 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130306P09 product:ATPase, Na+/K+ transporting, alpha 3 polypeptide, full insert sequence. [AK053751] KLA .88 .87 .74 .80 .84 .88 .93
ATP .96 .83 .80 .88 .94 .89 1.15
KLA/ATP .89 .86 .79 .90 .93 .84 .92
Atp1a3
KLA  ATP  ATP+KLA
 NM_144921 ATPase, Na+/K+ transporting, alpha 3 polypeptide (Atp1a3), mRNA [NM_144921] KLA .99 .87 .96 .86 .81 .61 .52
ATP 1.22 1.21 1.16 1.38 1.27 .92 1.30
KLA/ATP .96 1.10 1.17 1.42 1.11 .91 .93
Atp1b1
KLA  ATP  ATP+KLA
 NM_009721 ATPase, Na+/K+ transporting, beta 1 polypeptide (Atp1b1), mRNA [NM_009721] KLA .97 1.02 1.08 .98 .95 1.01 1.09
ATP 1.07 1.05 1.09 1.09 1.02 1.17 1.11
KLA/ATP .99 .99 .93 1.02 1.00 1.07 1.04
Atp1b2
KLA  ATP  ATP+KLA
 NM_013415 ATPase, Na+/K+ transporting, beta 2 polypeptide (Atp1b2), mRNA [NM_013415] KLA 1.18 1.09 1.11 1.12 1.16 1.12 1.15
ATP .95 .98 .99 1.26 1.06 1.10 1.07
KLA/ATP 1.15 1.16 1.09 1.19 1.27 1.13 1.02
Atp1b3
KLA  ATP  ATP+KLA
 NM_007502 ATPase, Na+/K+ transporting, beta 3 polypeptide (Atp1b3), mRNA [NM_007502] KLA 1.86 2.10 2.25 2.21 2.68 3.26 3.45
ATP 1.08 1.09 .93 1.13 1.55 2.14 2.38
KLA/ATP 1.95 2.10 1.84 2.34 2.20 2.96 4.69
Atp1b4
KLA  ATP  ATP+KLA
 NM_133690 ATPase, (Na+)/K+ transporting, beta 4 polypeptide (Atp1b4), mRNA [NM_133690] KLA .99 1.02 1.03 1.01 .95 .90 1.00
ATP 1.00 1.05 1.04 .98 1.07 .98 .97
KLA/ATP 1.00 1.05 1.03 1.04 .96 .97 1.01
Atp2b1
KLA  ATP  ATP+KLA
 AK053569 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130111D10 product:unclassifiable, full insert sequence. [AK053569] KLA 1.18 1.02 .86 .87 .88 .99 .97
ATP 1.38 1.60 8.03 2.45 1.66 1.16 .94
KLA/ATP 1.32 1.41 6.67 1.98 1.15 1.08 .96
Atp2b1
KLA  ATP  ATP+KLA
 AK161995 12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720440F18 product:Plasma membrane calcium pump isoform 1b (Fragment) homolog [Canis familiaris], full insert sequence. [AK16199 KLA 1.64 1.50 1.23 1.02 .71 .75 .92
ATP 1.04 1.12 1.69 1.64 1.34 1.03 .66
KLA/ATP 1.69 1.58 2.20 1.99 1.03 .67 .57
Atp2b1
KLA  ATP  ATP+KLA
 NM_026482 ATPase, Ca++ transporting, plasma membrane 1 (Atp2b1), mRNA [NM_026482] KLA 1.91 1.76 1.64 1.21 .84 .79 1.07
ATP 1.00 1.01 1.43 2.32 2.28 1.71 1.06
KLA/ATP 1.86 1.85 2.23 2.48 1.71 1.05 1.04
Atp2b2
KLA  ATP  ATP+KLA
 NM_009723 ATPase, Ca++ transporting, plasma membrane 2 (Atp2b2), transcript variant 1, mRNA [NM_009723] KLA 1.02 .93 1.01 1.01 1.04 1.00 1.09
ATP 1.00 1.03 1.01 1.05 1.05 1.04 .90
KLA/ATP .99 .95 1.04 1.06 1.01 .99 1.00
Atp2b3
KLA  ATP  ATP+KLA
 AK032322 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430519O13 product:PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASE 3 (EC 3.6.3.8) (PMCA3) (PLASMA MEMBRANE CALCIUM PUMP ISOFORM 3) (PLASMA MEMBRANE CALCIUM ATPASE ISOF KLA 1.00 1.05 1.01 1.09 1.00 1.04 1.09
ATP 1.02 .97 1.01 1.12 .95 1.19 1.16
KLA/ATP 1.01 .95 .97 1.09 1.12 1.06 1.14
Best2
KLA  ATP  ATP+KLA
 NM_145388 bestrophin 2 (Best2), mRNA [NM_145388] KLA 1.03 1.05 1.11 1.13 1.13 1.07 1.16
ATP .98 .99 1.23 1.88 1.85 1.47 1.14
KLA/ATP .99 1.03 1.25 1.35 2.25 1.60 1.16
Bst1
KLA  ATP  ATP+KLA
 NM_009763 bone marrow stromal cell antigen 1 (Bst1), mRNA [NM_009763] KLA 2.26 2.15 2.90 3.73 4.89 5.96 6.57
ATP 1.05 1.06 1.31 1.52 1.57 4.31 4.76
KLA/ATP 2.29 2.31 3.10 2.98 3.09 5.35 13.91
Calm1
KLA  ATP  ATP+KLA
 NM_009790 calmodulin 1 (Calm1), mRNA [NM_009790] KLA 1.20 1.26 1.30 1.06 1.16 1.09 1.18
ATP 1.07 1.20 1.00 1.29 .99 .64 .58
KLA/ATP 1.31 1.31 .93 1.31 .97 .83 .59
Calm2
KLA  ATP  ATP+KLA
 NM_007589 calmodulin 2 (Calm2), mRNA [NM_007589] KLA .79 .81 .71 .67 .54 .45 .64
ATP .99 1.03 1.04 .93 .82 .52 .76
KLA/ATP .76 .78 .76 .77 .73 .47 .42
Calm3
KLA  ATP  ATP+KLA
 NM_007590 calmodulin 3 (Calm3), mRNA [NM_007590] KLA .95 .96 .93 1.03 1.05 1.08 1.00
ATP .93 .96 .99 .97 .93 .84 .72
KLA/ATP .89 .93 .90 .91 1.02 .98 .70
Calm4
KLA  ATP  ATP+KLA
 NM_020036 calmodulin 4 (Calm4), mRNA [NM_020036] KLA 1.02 .96 1.05 1.00 .99 1.00 1.01
ATP 1.10 1.05 1.03 1.01 .94 .98 .98
KLA/ATP .99 1.12 1.01 1.03 .98 1.07 1.02
Calm5
KLA  ATP  ATP+KLA
 NM_001008706 calmodulin 5 (Calm5), mRNA [NM_001008706] KLA 1.02 1.11 .99 .98 1.07 1.01 1.09
ATP 1.07 1.05 1.04 1.04 1.01 1.04 .99
KLA/ATP 1.00 1.00 .97 1.07 1.00 1.07 .98
Calml3
KLA  ATP  ATP+KLA
 NM_027416 calmodulin-like 3 (Calml3), mRNA [NM_027416] KLA 1.01 .95 1.05 .91 1.01 .98 .89
ATP .91 1.05 1.04 1.01 .93 1.07 .99
KLA/ATP 1.01 .96 .97 .96 .97 .92 .99
Camp
KLA  ATP  ATP+KLA
 NM_009921 cathelicidin antimicrobial peptide (Camp), mRNA [NM_009921] KLA 2.06 1.98 2.14 1.70 1.91 1.76 2.16
ATP 1.37 1.37 1.44 1.73 1.80 1.62 1.27
KLA/ATP 2.03 2.12 2.47 2.63 2.16 1.58 1.90
Cd38
KLA  ATP  ATP+KLA
 NM_007646 CD38 antigen (Cd38), mRNA [NM_007646] KLA 3.61 5.39 8.63 9.62 24.42 36.25 76.13
ATP 1.00 1.05 1.36 1.70 2.26 8.41 7.84
KLA/ATP 4.45 4.89 5.01 7.93 5.74 14.08 40.05
Chrm3
KLA  ATP  ATP+KLA
 AK051841 12 days embryo eyeball cDNA, RIKEN full-length enriched library, clone:D230008K23 product:unclassifiable, full insert sequence. [AK051841] KLA .92 .97 1.02 1.05 .96 .99 1.00
ATP 1.00 .99 .99 .95 1.05 1.02 1.01
KLA/ATP .91 .98 1.06 1.07 .94 1.00 .94
Chrm3
KLA  ATP  ATP+KLA
 NM_033269 cholinergic receptor, muscarinic 3, cardiac (Chrm3), mRNA [NM_033269] KLA .91 .99 .98 .93 1.08 1.01 1.06
ATP .97 1.05 1.03 .95 .99 1.01 1.10
KLA/ATP 1.05 1.09 .99 1.00 .98 1.03 1.00
Cst3
KLA  ATP  ATP+KLA
 NM_009976 cystatin C (Cst3), mRNA [NM_009976] KLA .99 .89 .94 .83 1.09 .97 .85
ATP 1.15 1.26 .83 1.06 1.03 .96 1.25
KLA/ATP .95 .98 .85 1.13 .84 .82 1.30
Dmbt1
KLA  ATP  ATP+KLA
 NM_007769 deleted in malignant brain tumors 1 (Dmbt1), mRNA [NM_007769] KLA 1.04 1.01 1.04 1.13 1.03 1.03 1.24
ATP 1.03 1.04 1.02 1.08 1.13 1.07 1.13
KLA/ATP 1.04 1.07 1.08 1.04 1.12 1.16 1.18
Fxyd2
KLA  ATP  ATP+KLA
 NM_052823 FXYD domain-containing ion transport regulator 2 (Fxyd2), transcript variant b, mRNA [NM_052823] KLA 1.07 .97 1.09 .98 1.02 .96 .83
ATP 1.07 1.22 1.00 1.14 1.00 1.22 4.11
KLA/ATP 1.06 1.11 .96 1.13 .98 1.01 1.02
Gnaq
KLA  ATP  ATP+KLA
 NM_008139 guanine nucleotide binding protein, alpha q polypeptide (Gnaq), mRNA [NM_008139] KLA .82 .82 .69 .64 .60 .55 .55
ATP 1.06 1.02 .87 .67 .50 .66 .57
KLA/ATP .82 .79 .66 .55 .41 .33 .48
Gnas
KLA  ATP  ATP+KLA
 AF107847 neuroendocrine-specific Golgi protein p55 isoform 1 (XLalphas) alternatively spliced mRNA, complete cds. [AF107847] KLA 1.04 .94 1.00 1.05 1.04 .98 1.00
ATP .98 .97 .96 1.00 .99 .98 1.02
KLA/ATP 1.04 1.02 .96 .95 1.01 .96 1.01
Gnas
KLA  ATP  ATP+KLA
 AK017423 10 days neonate head cDNA, RIKEN full-length enriched library, clone:5530400H20 product:novel noncoding RNA overlapping the exon 1A, 1 and 2 of Gnas, full insert sequence. [AK017423] KLA .85 1.08 .97 .92 1.05 1.03 1.08
ATP .99 1.30 2.11 1.73 1.23 1.01 1.02
KLA/ATP .96 1.06 1.58 1.34 1.29 1.05 .91
Gnas
KLA  ATP  ATP+KLA
 NM_001077510 GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus (Gnas), transcript variant 8, mRNA [NM_001077510] KLA .99 1.03 .97 .91 1.03 .95 .97
ATP 1.04 1.19 1.15 1.61 1.24 .91 1.00
KLA/ATP 1.06 .97 1.01 1.46 1.04 .85 1.01
Gnas
KLA  ATP  ATP+KLA
 S49980 gb|stimulatory G protein alpha subunit {clone WC-16} [mice, whole cochlea, mRNA Partial, 356 nt]. [S49980] KLA .91 .88 1.03 .87 .90 .84 1.01
ATP 1.16 1.22 1.02 1.55 1.16 .80 .99
KLA/ATP 1.01 1.13 .86 1.12 .97 .85 1.08
Gucy1a3
KLA  ATP  ATP+KLA
 NM_021896 guanylate cyclase 1, soluble, alpha 3 (Gucy1a3), mRNA [NM_021896] KLA 1.01 1.01 1.04 .99 .99 .97 .99
ATP .99 1.01 .99 .99 .97 1.02 1.02
KLA/ATP 1.00 .96 1.00 .99 .98 1.04 .99
Gucy1b2
KLA  ATP  ATP+KLA
 NM_172810 guanylate cyclase 1, soluble, beta 2 (Gucy1b2), mRNA [NM_172810] KLA 1.02 1.03 1.03 1.09 .95 1.06 .91
ATP 1.01 1.03 1.01 1.08 .96 1.04 .90
KLA/ATP 1.04 1.03 .99 1.05 .97 .96 .84
Gucy1b3
KLA  ATP  ATP+KLA
 NM_017469 guanylate cyclase 1, soluble, beta 3 (Gucy1b3), mRNA [NM_017469] KLA .99 .99 .99 1.01 .98 .98 1.00
ATP .98 .98 .98 .98 .98 1.00 1.01
KLA/ATP .96 .99 .98 1.01 .99 .99 .99
Itpr1
KLA  ATP  ATP+KLA
 NM_010585 inositol 1,4,5-triphosphate receptor 1 (Itpr1), mRNA [NM_010585] KLA 3.66 3.69 6.74 8.11 7.08 4.40 1.22
ATP 1.08 .95 1.19 .94 1.09 1.00 .68
KLA/ATP 3.48 3.58 5.86 6.03 4.01 2.31 .97
Itpr2
KLA  ATP  ATP+KLA
 NM_019923 inositol 1,4,5-triphosphate receptor 2 (Itpr2), transcript variant 1, mRNA [NM_019923] KLA 1.41 1.38 1.43 1.42 1.30 1.07 1.01
ATP 1.00 1.00 .97 .97 1.07 1.15 1.06
KLA/ATP 1.39 1.48 1.64 1.42 1.07 .83 .95
Itpr3
KLA  ATP  ATP+KLA
 NM_080553 inositol 1,4,5-triphosphate receptor 3 (Itpr3), mRNA [NM_080553] KLA .55 .51 .45 .41 .34 .34 .45
ATP 1.01 .92 1.02 .57 .46 .34 1.22
KLA/ATP .56 .48 .48 .29 .33 .27 .65
Kcnma1
KLA  ATP  ATP+KLA
 NM_010610 potassium large conductance calcium-activated channel, subfamily M, alpha member 1 (Kcnma1), mRNA [NM_010610] KLA 1.04 1.08 .96 .98 1.01 1.08 .96
ATP 1.03 .96 .99 .97 .98 .95 .99
KLA/ATP .99 1.07 1.04 1.04 .99 .95 .93
Kcnn4
KLA  ATP  ATP+KLA
 NM_008433 potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 (Kcnn4), mRNA [NM_008433] KLA .89 .85 .74 .69 .78 1.04 .98
ATP .95 1.03 .82 .84 .81 .44 .70
KLA/ATP 1.04 .94 .65 .74 .56 .43 .57
Lpo
KLA  ATP  ATP+KLA
 NM_080420 lactoperoxidase (Lpo), mRNA [NM_080420] KLA 1.26 1.28 1.37 1.46 1.33 1.35 1.14
ATP 1.00 1.01 1.22 1.23 1.21 1.26 1.20
KLA/ATP 1.33 1.54 1.79 1.52 1.52 1.47 1.31
Lyz1
KLA  ATP  ATP+KLA
 NM_013590 lysozyme 1 (Lyz1), mRNA [NM_013590] KLA .75 .75 .78 .69 .72 .59 .90
ATP 1.10 1.16 .86 .93 .90 .68 .71
KLA/ATP .95 .84 .63 .79 .58 .55 .40
Lyz2
KLA  ATP  ATP+KLA
 AK159276 osteoclast-like cell cDNA, RIKEN full-length enriched library, clone:I420013M05 product:lysozyme, full insert sequence [AK159276] KLA .77 .74 .77 .80 .69 .63 .82
ATP .95 .84 1.04 .80 .86 .83 .68
KLA/ATP .74 .66 .89 .72 .75 .67 .40
Lyz2
KLA  ATP  ATP+KLA
 NM_017372 lysozyme 2 (Lyz2), mRNA [NM_017372] KLA .81 .80 .90 .70 .80 .70 .92
ATP 1.12 1.28 .85 1.14 1.04 .86 .75
KLA/ATP 1.02 .97 .65 .94 .63 .74 .57
Mm.20075
2
KLA  ATP  ATP+KLA
 147905739 Unknown KLA .95 1.01 .99 1.01 1.00 1.01 1.05
ATP .90 .98 1.00 .98 .99 .95 1.01
KLA/ATP .95 .98 1.06 .95 .95 .99 1.05
Mm.24987
3
KLA  ATP  ATP+KLA
 161621251 Unknown KLA 1.11 1.02 1.08 1.36 1.47 1.64 3.59
ATP 1.05 1.00 1.00 .96 1.04 1.20 1.13
KLA/ATP 1.08 1.12 1.23 1.06 1.09 1.31 1.81
Mm.41137
KLA  ATP  ATP+KLA
 148747308 Unknown KLA 1.03 1.00 .95 .92 1.04 .98 .96
ATP 1.02 .98 .98 .90 .95 .92 1.07
KLA/ATP .91 .89 1.01 .95 1.00 .96 .99
Mm.44160
1
KLA  ATP  ATP+KLA
 145966786 Unknown KLA 1.08 .94 1.01 .97 .79 .78 .71
ATP 1.09 .92 1.10 .75 .65 .92 .69
KLA/ATP 1.01 .92 1.16 .81 .69 .56 .63
Muc5b
KLA  ATP  ATP+KLA
 NM_028801 mucin 5, subtype B, tracheobronchial (Muc5b), mRNA [NM_028801] KLA .93 .98 1.06 1.02 .95 .92 1.00
ATP .98 .96 1.18 1.13 1.01 .94 .96
KLA/ATP 1.00 .98 1.02 1.03 .95 .97 1.00
Nos1
KLA  ATP  ATP+KLA
 NM_008712 nitric oxide synthase 1, neuronal (Nos1), mRNA [NM_008712] KLA 1.01 1.01 1.02 .99 1.02 1.02 1.01
ATP 1.01 1.03 1.02 1.04 1.03 1.01 1.00
KLA/ATP 1.05 1.02 1.02 1.00 1.02 1.03 1.03
Plcb1
KLA  ATP  ATP+KLA
 AK129166 mRNA for mKIAA0581 protein [AK129166] KLA 1.02 .98 .91 .91 .92 .95 .89
ATP 1.03 1.02 1.02 1.01 .90 1.02 1.04
KLA/ATP .98 .97 .91 .93 .92 1.01 1.16
Plcb1
KLA  ATP  ATP+KLA
 NM_019677 phospholipase C, beta 1 (Plcb1), mRNA [NM_019677] KLA .99 .94 .95 .97 .93 .92 .91
ATP 1.00 .96 .99 .95 .99 1.03 .98
KLA/ATP .93 .96 .94 .93 .87 1.00 1.06
Plcb2
KLA  ATP  ATP+KLA
 NM_177568 phospholipase C, beta 2 (Plcb2), mRNA [NM_177568] KLA .70 .68 .64 .67 .65 .76 .88
ATP .95 .94 1.04 .94 .72 .57 1.19
KLA/ATP .69 .68 .72 .63 .65 .55 .70
Plcb3
KLA  ATP  ATP+KLA
 NM_008874 phospholipase C, beta 3 (Plcb3), mRNA [NM_008874] KLA 1.72 1.78 1.82 1.65 1.67 1.44 1.21
ATP .97 1.04 .81 .87 .78 .88 .94
KLA/ATP 1.69 1.89 1.44 1.66 1.12 .73 .93
Plcb4
KLA  ATP  ATP+KLA
 AK082509 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230058B11 product:unclassifiable, full insert sequence. [AK082509] KLA 1.06 1.03 .97 .98 1.02 1.01 .99
ATP .99 1.07 1.09 .95 .97 .97 1.02
KLA/ATP .98 1.00 1.03 .96 1.02 .91 .98
Plcb4
KLA  ATP  ATP+KLA
 NM_013829 phospholipase C, beta 4 (Plcb4), mRNA [NM_013829] KLA .88 .94 .81 .82 .81 .86 1.01
ATP 1.00 1.01 .92 .93 .88 .85 .89
KLA/ATP .97 .94 .78 .80 .78 .86 .97
Prb1
KLA  ATP  ATP+KLA
 NM_198669 proline-rich protein BstNI subfamily 1 (Prb1), mRNA [NM_198669] KLA .98 .94 1.07 .96 1.00 .98 1.09
ATP 1.14 .98 1.00 .97 .98 1.00 .99
KLA/ATP 1.00 1.05 1.09 .98 1.08 1.03 1.01
Prkaca
KLA  ATP  ATP+KLA
 NM_008854 protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] KLA .71 .74 .72 .70 .72 .84 .85
ATP 1.05 .98 .89 .92 .76 .60 1.02
KLA/ATP .79 .74 .55 .65 .60 .65 .93
Prkacb
KLA  ATP  ATP+KLA
 NM_011100 protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] KLA .69 .70 .66 .58 .51 .55 .59
ATP 1.02 1.19 .97 1.01 .69 .38 .56
KLA/ATP .72 .73 .57 .62 .47 .41 .45
Prkca
KLA  ATP  ATP+KLA
 NM_011101 protein kinase C, alpha (Prkca), mRNA [NM_011101] KLA 1.00 .96 .94 .95 .95 .89 .96
ATP 1.00 1.03 .91 .94 .82 .87 1.13
KLA/ATP 1.02 .95 .91 .86 .78 .84 .94
Prkcb1
KLA  ATP  ATP+KLA
 NM_008855 protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] KLA .92 .95 .93 .78 .77 1.08 1.83
ATP 1.03 1.12 1.09 1.23 .90 2.08 .96
KLA/ATP .98 .99 .82 .89 .62 1.01 1.08
Prkcc
KLA  ATP  ATP+KLA
 NM_011102 protein kinase C, gamma (Prkcc), mRNA [NM_011102] KLA 1.02 1.04 1.11 1.04 .96 1.02 1.05
ATP .98 .98 1.05 1.03 1.08 .96 .95
KLA/ATP 1.21 1.16 1.09 1.07 1.04 .98 .93
Prkg1
KLA  ATP  ATP+KLA
 NM_011160 protein kinase, cGMP-dependent, type I (Prkg1), transcript variant 2, mRNA [NM_011160] KLA .97 .96 .97 1.08 1.11 .93 .94
ATP 1.07 .96 .94 .99 1.03 1.60 .90
KLA/ATP .95 1.07 1.00 1.04 1.00 1.04 .91
Prkg2
KLA  ATP  ATP+KLA
 NM_008926 protein kinase, cGMP-dependent, type II (Prkg2), mRNA [NM_008926] KLA .97 1.03 1.03 1.02 1.15 .99 .98
ATP 1.02 1.08 .98 .98 1.00 1.00 1.02
KLA/ATP 1.01 1.02 1.03 .97 1.00 .93 1.02
Prkx
KLA  ATP  ATP+KLA
 NM_016979 protein kinase, X-linked (Prkx), mRNA [NM_016979] KLA 3.61 3.79 4.67 4.66 4.85 4.19 1.43
ATP .98 .90 .63 .61 1.12 1.90 1.29
KLA/ATP 3.56 3.36 2.62 2.06 2.26 2.87 2.31
Ryr3
KLA  ATP  ATP+KLA
 BC116740 ryanodine receptor 3, mRNA (cDNA clone IMAGE:40126059), complete cds. [BC116740] KLA .99 .95 .96 1.08 1.04 1.01 1.02
ATP 1.06 1.02 1.00 1.03 1.01 .96 1.04
KLA/ATP 1.06 .98 .90 1.06 1.06 .97 1.06
Ryr3
KLA  ATP  ATP+KLA
 NM_177652 ryanodine receptor 3 (Ryr3), mRNA [NM_177652] KLA 1.04 1.02 1.03 1.03 1.04 1.04 1.03
ATP .97 .96 .99 1.06 .98 1.00 1.01
KLA/ATP 1.03 1.02 1.01 1.03 1.02 1.02 1.01
Slc12a2
KLA  ATP  ATP+KLA
 NM_009194 solute carrier family 12, member 2 (Slc12a2), mRNA [NM_009194] KLA 1.17 1.01 1.01 1.02 .79 .76 .79
ATP 1.09 1.09 1.16 1.56 1.42 1.40 .78
KLA/ATP 1.07 1.19 1.40 1.55 1.18 1.11 .85
Slc4a2
KLA  ATP  ATP+KLA
 NM_009207 solute carrier family 4 (anion exchanger), member 2 (Slc4a2), mRNA [NM_009207] KLA .96 .89 1.01 .78 .99 .85 .89
ATP 1.26 1.27 .48 .61 .70 .78 1.49
KLA/ATP 1.18 1.11 .49 .63 .67 .69 1.52
Slc9a1
KLA  ATP  ATP+KLA
 NM_016981 solute carrier family 9 (sodium/hydrogen exchanger), member 1 (Slc9a1), mRNA [NM_016981] KLA 1.74 1.72 1.95 1.84 1.86 1.53 1.49
ATP 1.11 1.28 .95 1.46 1.98 2.67 1.47
KLA/ATP 1.85 2.02 1.70 2.47 2.18 3.18 3.48
Slc9a1
KLA  ATP  ATP+KLA
 U51112 Na+/H+ exchanger (NHE-1) mRNA, complete cds. [U51112] KLA 1.78 1.83 2.11 1.90 1.91 1.61 1.40
ATP 1.07 1.14 .98 1.54 2.00 2.85 1.44
KLA/ATP 1.97 2.16 2.01 2.44 2.30 3.37 3.15
Trpv6
KLA  ATP  ATP+KLA
 NM_022413 transient receptor potential cation channel, subfamily V, member 6 (Trpv6), mRNA [NM_022413] KLA .97 .96 1.01 1.01 .99 .96 1.03
ATP 1.04 .99 .96 .99 1.01 1.00 .80
KLA/ATP 1.06 .99 1.02 1.01 .97 .97 .99
Vamp2
KLA  ATP  ATP+KLA
 NM_009497 vesicle-associated membrane protein 2 (Vamp2), mRNA [NM_009497] KLA .99 1.02 1.03 1.07 1.34 1.25 1.58
ATP 1.03 1.12 .88 1.22 .94 .99 1.62
KLA/ATP 1.03 1.15 .82 1.10 .87 .93 1.86